Talmadge Layne Crowe, MD | |
9150 Jewel Lake Rd, Suite B, Anchorage, AK 99502-5381 | |
(907) 333-8561 | |
(907) 333-8560 |
Full Name | Talmadge Layne Crowe |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 35 Years |
Location | 9150 Jewel Lake Rd, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942319611 | NPI | - | NPPES |
MD17721 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 3449 (Alaska) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Urgent Care Medical Clinic Pc | 8123918513 | 4 |
News Archive
"In the last of its series called '7 Billion: Conversations That Matter,' Aspen Institute's Global Health and Development on Wednesday hosted a panel of experts based in Africa and the United States on the interconnectedness of gender issues, family planning, population, and access to safe water," GlobalPost's "Global Pulse" blog reports.
Sermo, the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the treatment of breast cancer.
Taro Pharmaceutical Industries Ltd. today provided preliminary, unaudited and unreviewed information on its financial performance for the first quarter of 2010.
Watson Pharmaceuticals, Inc. has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its Levonorgestrel and Ethinyl Estradiol tablets, USP (0.09 mg/0.02 mg) extended-cycle oral contraceptive product prior to the expiration of patents owned by Wyeth.
› Verified 1 days ago
Entity Name | Urgent Care Medical Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497781678 PECOS PAC ID: 8123918513 Enrollment ID: O20040318001007 |
News Archive
"In the last of its series called '7 Billion: Conversations That Matter,' Aspen Institute's Global Health and Development on Wednesday hosted a panel of experts based in Africa and the United States on the interconnectedness of gender issues, family planning, population, and access to safe water," GlobalPost's "Global Pulse" blog reports.
Sermo, the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the treatment of breast cancer.
Taro Pharmaceutical Industries Ltd. today provided preliminary, unaudited and unreviewed information on its financial performance for the first quarter of 2010.
Watson Pharmaceuticals, Inc. has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its Levonorgestrel and Ethinyl Estradiol tablets, USP (0.09 mg/0.02 mg) extended-cycle oral contraceptive product prior to the expiration of patents owned by Wyeth.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Talmadge Layne Crowe, MD 9150 Jewel Lake Rd, Anchorage, AK 99502-5381 Ph: (907) 248-8561 | Talmadge Layne Crowe, MD 9150 Jewel Lake Rd, Suite B, Anchorage, AK 99502-5381 Ph: (907) 333-8561 |
News Archive
"In the last of its series called '7 Billion: Conversations That Matter,' Aspen Institute's Global Health and Development on Wednesday hosted a panel of experts based in Africa and the United States on the interconnectedness of gender issues, family planning, population, and access to safe water," GlobalPost's "Global Pulse" blog reports.
Sermo, the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the treatment of breast cancer.
Taro Pharmaceutical Industries Ltd. today provided preliminary, unaudited and unreviewed information on its financial performance for the first quarter of 2010.
Watson Pharmaceuticals, Inc. has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its Levonorgestrel and Ethinyl Estradiol tablets, USP (0.09 mg/0.02 mg) extended-cycle oral contraceptive product prior to the expiration of patents owned by Wyeth.
› Verified 1 days ago
Candace L Clawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1624 Fax: 907-729-1634 | |
Dr. William Murray Buttner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-561-4806 | |
Robert L Mcalister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-2992 | |
Shane W Cummings, M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515 Phone: 907-344-2400 Fax: 907-344-2404 | |
Jeremy D Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Compassion Cir, Anchorage, AK 99504 Phone: 907-212-9200 Fax: 907-212-9283 | |
Kelton Hillard Oliver, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12302 Woodward Dr, Anchorage, AK 99516 Phone: 907-580-0002 | |
Ryan T. Mcwilliams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508 Phone: 907-729-6321 |